In partnership with Potawatomi Casino Hotel, Milwaukee Public Museum (MPM) is honoring Native American Heritage Month this November with special programming, events and free admission days that ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Today, MPM Capital (“MPM”), one of the world’s leading biotech investment firms, announced that it has raised $850 million for its second Oncology Impact Fund (“OIF ...
Jan 5 (Reuters) - Aktis Oncology is seeking a valuation of as much as $840 million in its U.S. initial public offering, the biotechnology company backed by major sector investor MPM BioImpact revealed ...
On January 12, 2026, MPM Funds purchased 1,112,777 shares of Aktis Oncology, Inc. (NASDAQ:AKTS) at a price of $18.00 per share, for a total transaction value of $20,029,986. AKTS shares currently ...
Biotech investor MPM Capital has put together a $400 million new fund with help from Big Pharma, scouting for innovative startups with an eye on build-to-buy deals ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--MPM Capital (MPM), one of the world’s prominent biotech investment firms, has announced the addition of Detlev Biniszkiewicz, Ph.D. to its venture investment team as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback